Finally, while we focused here on the role of BRN2 in melanoma, we observed that depletion of BRN2 in neuroblastoma cells following cisplatin treatment increased apoptosis, indicating that the ability of BRN2 to modulate the apoptotic response is not restricted to melanoma. The gene discussed is POU3F2; the disease is melanoma.